Seeking Alpha
 

Sarepta Therapeutics, Inc. (SRPT)

- NASDAQ
  • InvestingInsights | Send Message 20 Jul

    $SRPT Roth Capital Pounds the Table on Sarepta Therapeutics Inc (SRPT) http://bit.ly/1CLTILa
    Reply
      • beleggersclub | Send Message 19 Jul

        CONFIRMED breakout $NSM, $W, $SRPT http://bit.ly/1RHHzxq
        Reply
          • InvestingInsights | Send Message 30 Jun

            $SRPT Oppenheimer Maintains Outperform on Sarepta Therapeutics Following Completed Rolling NDA for Eteplirsen http://tinyurl.com/p9dl6qq
            Reply
              • wazzaofwallst | Send Message 29 Jun

                $SRPT CEO compensation and management tenure is certainly an interesting one: http://tinyurl.com/ngbfxq3
                Reply
                  • Life Sciences Report | Send Message 3 Jun

                    An Undervalued Biotech Is Testing The Cure For Cancer Now, And Chen Lin Wants In $PTBI, $SRNE, $SRPT http://seekingalpha.com/p/2f1mq
                    Reply (1)
                    • BiotechX | Send Message 6 Jun
                      : Excellent article - SRNE is overseen in the CAR-T cell space and has a unique cell technology which differentiates from JUNO and KITE
                      • Seraphim Blentzas | Send Message 31 May

                        Alexion Pharmaceuticals $ALXN Organic Growth Potential Kanuma Soliris $AGIO $GEVA $MRK $RHHBY $SRPT $AMGN http://tinyurl.com/oq5s9ld
                        Reply
                          • InvestingInsights | Send Message 22 May

                            $SRPT WBB Securities Raises Price Target For Sarepta Therapeutics Following Positive Pre-NDA Meeting With FDA http://bit.ly/1LsR5xE
                            Reply
                              • WarriorTrading | Send Message 21 May

                                Sarepta Therapeutics Inc (NASDAQ: SRPT) Soars 60% $SRPT http://seekingalpha.com/p/2e8no
                                Reply
                                  • InvestingInsights | Send Message 21 May

                                    $SRPT Roth Capital Defends Sarepta Therapeutics Inc Following Negative Wall Street Journal Article http://bit.ly/1c7UbKA
                                    Reply
                                      • jdamlan | Send Message 20 May

                                        $SRPT will file a NDA with the FDA. Will this be the newest blockbuster drug? http://bit.ly/1Bc65Kb
                                        Reply
                                          Visit Seeking Alpha's
                                          SRPT vs. ETF Alternatives
                                          Company Description
                                          Sarepta Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of rare, infectious and other diseases.
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States